FrancophonIA/ELRC3.0 huggingface dataset:
English: Lixisenatide
Danish: Lixisenatid
English: Lyxumia should not be used if it has been frozen.
Danish: Lyxumia må ikke anvendes, hvis lægemidlet har været frosset.
English: Common side effects: may affect up to 1 in 10 people
Danish: Almindelige bivirkninger: kan forekomme hos 1 ud af 10 patienter
English: - The other ingredients are glycerol 85 %, sodium acetate trihydrate, methionine, metacresol, hydrochloric acid (for pH adjustment), sodium hydroxide solution (for pH adjustment) and water for injections.
Danish: - Øvrige indholdsstoffer: Glycerol 85 %, natriumacetattrihydrat, methionin, metacresol, saltsyre (til pH-justering), natriumhydroxidopløsning (til pH-justering) og vand til injektionsvæsker.
English: • Do not try to take liquid out of the cartridge using a syringe.
Danish: • Forsøg ikke at trække væske ud af cylinderampullen med en sprøjte.
English: In addition, a double-blind, placebo-controlled cardiovascular outcome study (ELIXA) enrolled 6,068 type 2 diabetes patients with previous acute coronary syndrome (3,034 randomised to lixisenatide,
Danish: Endvidere, et dobbeltblindet, placebokontrolleret kardiovaskulært endepunktsstudium (ELIXA) omfattende 6.068 patienter med type 2-diabetes med tidligere akut koronarsyndrom (3.034
English: If you forget to use Lyxumia
Danish: Hvis du har glemt at tage Lyxumia
English: Each pack of 2 pre-filled pens for a 4 week treatment schedule contains: 1 pre-filled pen of 3 ml for 14 doses of 10 micrograms 1 pre-filled pen of 3 ml for 14 doses of 20 micrograms
Danish: Hver pakning med 2 fyldte penne beregnet til 4 ugers behandlingsregime indeholder: 1 fyldt pen af 3 ml med 14 doser af 10 mikrogram 1 fyldt pen af 3 ml med 14 doser af 20 mikrogram
English: If you use Lyxumia with a sulphonylurea or a basal insulin, you may get low blood sugar (hypoglycaemia).
Danish: Hvis du tager Lyxumia sammen med et sulfonylurinstof eller basalinsulin, kan du få lavt blodsukker (hypoglykæmi).
English: There is no therapeutic experience in patients with severe renal impairment (creatinine clearance less than 30 ml/min) or end-stage renal disease.
Danish: Der er ingen terapeutisk erfaring med patienter med svært nedsat nyrefunktion (kreatinin-clearance mindre end 30 ml/min.)
English: Patients receiving Lyxumia with a sulphonylurea or with a basal insulin may have an increased risk of hypoglycaemia.
Danish: Patienter, der får Lyxumia sammen med et sulfonylurinstof eller basalinsulin, kan have en øget risiko for hypoglykæmi.
English: 1 pre-filled pen of 3 ml (14 doses) 2 pre-filled pens of 3 ml (2x14 doses) 6 pre-filled pens of 3 ml (6x14 doses)
Danish: Injektionsvæske, opløsning 1 fyldt pen af 3 ml (14 doser) 2 fyldte penne af 3 ml (2x14 doser) 6 fyldte penne af 3 ml (6x14 doser)
English: Reduction of the dose of the sulphonylurea or the basal insulin may be considered to reduce the risk of hypoglycaemia (see section 4.2).
Danish: Reduktion af dosis af sulfonylurinstof eller basalinsulin kan overvejes for at reducere risikoen for hypoglykæmi (se pkt.
English: When lixisenatide 20 mcg and atorvastatin 40 mg were co-administered in the morning for 6 days, the exposure to atorvastatin was not affected, while Cmax was decreased by 31% and tmax was delayed by 3.25 hours.
Danish: Når lixisenatid 20 µg og atorvastatin 40 mg blev indgivet samtidig om morgenen i 6 dage, påvirkede det ikke eksponeringen for atorvastatin, mens Cmax sænkedes med 31 % og tmax forsinkedes med 3,25 timer.
English: България sanofi-aventis Bulgaria EOOD Тел.
Danish: България sanofi-aventis Bulgaria EOOD
English: Lyxumia 20 micrograms solution for injection EU/1/12/811/002 (1 pre-filled pen) EU/1/12/811/003 (2 pre-filled pens) EU/1/12/811/004 (6 pre-filled pens)
Danish: Lyxumia 20 mikrogram injektionsvæske, opløsning EU/1/12/811/002 (1 fyldt pen) EU/1/12/811/003 (2 fyldte penne) EU/1/12/811/004 (6 fyldte penne)
English: Hypoglycaemia (in combination with a sulphonylurea and / or a basal insulin)
Danish: Hypoglykæmi (i kombination med et sulfonylurinstof og/eller basalinsulin)
English: Step 1 Pull off the pen cap and check the pen
Danish: Trin A Tag pennens hætte af og kontroller pennen
English: Add-on treatment to pioglitazone alone or in combination with metformin
Danish: Tillægsbehandling til pioglitazon alene eller i kombination med metformin
English: • Handle your Lyxumia pen with care.
Danish: • Behandl din Lyxumia-pen forsigtigt.
English: After activation of the pen:
Danish: Efter aktivering af pennen
English: When Lyxumia is added to existing therapy of a sulphonylurea or a basal insulin, a reduction in the dose of the sulphonylurea or the basal insulin may be considered to reduce the risk of hypoglycaemia.
Danish: Når Lyxumia tilføjes til igangværende sulfonylurinstofbehandling eller basalinsulin, kan det overvejes at reducere dosis af sulfonylurinstof eller basalinsulin for at reducere risikoen for hypoglykæmi.
English: Table 2: Placebo-controlled studies in combination with metformin (24-week results).
Danish: Tabel 2: Placebokontrollerede studier i kombination med metformin (24-ugers resultater).
English: When you are not using the pen, keep the cap on the pen in order to protect from light.
Danish: Når du ikke bruger pennen, skal hætten sættes på pennen igen for at beskytte mod lys.
English: Lyxumia is used with other medicines for diabetes when they are not enough to control your blood sugar levels.These may include:
Danish: Lyxumia bruges sammen med andre lægemidler til diabetes, når de ikke er tilstrækkelige til at kontrollere blodsukkerniveauet.
English: Treatment with Lyxumia in combination with metformin and/or a sulphonylurea resulted in a sustained body weight change from baseline in all controlled studies in a range from -1.76 kg to2.96 kg at the end of the main 24-week treatment period.
Danish: Behandling med Lyxumia i kombination med metformin og/eller et sulfonylurinstof medførte en vedvarende ændring af legemsvægten fra baseline i alle kontrollerede studier på mellem -1,76 kg og2,96 kg ved afslutning af den 24-ugers behandlingsperiode.
English: LS mean change from baseline
Danish: MK*-middelændring fra baseline
English: Add-on treatment to a sulphonylurea alone or in combination with metformin
Danish: Tillægsbehandling til et sulfonylurinstof alene eller i kombination med metformin
English: During clinical studies, doses up to 30 mcg of lixisenatide twice a day were administered to type 2 diabetic patients in a 13-week study.
Danish: Der er givet doser på op til 30 µg lixisenatid to gange dagligt til type 2-diabetespatienter i et 13-ugers studium.
English: Lyxumia in combination with metformin, a sulphonylurea, pioglitazone or a combination of these agents showed statistically significant reductions in HbA1c, in fasting plasma glucose and in 2-hour post-prandial glucose after a test-meal compared to placebo at the end of the main 24-week treatment period (tables 2 and 3).
Danish: Lyxumia i kombination med metformin, et sulfonylurinstof, pioglitazon eller en kombination af disse midler viste statistisk signifikant reduktion i HbA1c, i fastende plasmaglucose og i 2-timers postprandial glucose efter et testmåltid sammenlignet med placebo ved afslutning af den 24-ugers behandlingsperiode (tabel 2 og 3).
English: Insulin glulisine TID
Danish: Lixisenatid Insulin glulisin
English: In an active-controlled study, Lyxumia once daily showed an HbA1c reduction of -0.79% compared to -0.96% with exenatide twice daily at the end of the main 24-week treatment period with a mean treatment difference of 0.17% (95%CI: 0.033, 0.297) and a similar percentage of patients achieved an HbA1c less than 7% in the lixisenatide group (48.5%) and in the exenatide group (49.8%).
Danish: I et aktivt kontrolleret klinisk studium medførte behandling med Lyxumia én gang dagligt en HbA1creduktion på -0,79 % sammenlignet med -0,96 % med exenatid to gange dagligt ved afslutning af den 24-ugers behandlingsperiode (med en gennemsnitlig behandlingsforskel på 0,17 % (95 % CI: 0,033; 0,297) og en sammenlignelig del af patienterne opnåede en HbA1c på mindre end 7 % i lixisenatidgruppen (48,5 %) og i exenatidgruppen (49,8 %).
English: After concomitant administration of lixisenatide 20 mcg and ramipril 5 mg during 6 days, the AUC of ramipril was increased by 21% while the Cmax was decreased by 63%.
Danish: Efter samtidig administration af lixisenatid 20 µg og ramipril 5 mg i 6 dage øgedes AUC for ramipril med 21 %, mens Cmax sænkedes med 63 %.
English: Based on these results, no dose adjustment for digoxin is required when co-administered with lixisenatide.
Danish: Baseret på disse resultater kræves der ingen dosisjustering for digoxin ved administration samtidig med lixisenatid.
English: Hepatic dysfunction is not expected to affect the pharmacokinetics of lixisenatide.
Danish: Leverdysfunktion forventes ikke at påvirke farmakokinetikken for lixisenatid.
English: About Your Lyxumia pens Green 10 microgram Lyxumia pen
Danish: Om dine Lyxumia-penne Grøn 10 mikrogram Lyxumia-pen
English: What Lyxumia looks like and contents of the pack Lyxumia is a clear and colourless solution for injection (injection) filled in a glass cartridge inserted in a pre-filled pen.
Danish: Lyxumia er en klar, farveløs injektionsvæske, opløsning (injektion) påfyldt en cylinderampul af glas, der er monteret i en fyldt pen.
English: Before activation of the pen:
Danish: Før aktivering af pennen
English: Step 2 Attach a needle and remove the needle caps
Danish: Trin 2 Påsæt en nål og fjern nålehylster og nålekapsel
English: Check that the activation window is now white.
Danish: Kontroller, at aktiveringsvinduet nu er hvidt.
English: EXP Discard pen 14 days after first use
Danish: EXP Kassér pennen 14 dage efter at den er taget i brug.
English: Step 4 Press and hold the injection button to remove excess liquid
Danish: Trin 4 Tryk og hold injektionsknappen inde for at fjerne overskydende væske
English: The incidence of treatment discontinuation due to adverse events was 7.4% for Lyxumia compared to 3.2% in the placebo group during the main 24-week treatment period.
Danish: Forekomsten af behandlingsophør på grund af bivirkninger var 7,4 % for Lyxumia sammenlignet med 3,2 % i placebogruppen under den 24-ugers behandlingsperiode.
English: In patients taking Lyxumia in monotherapy, symptomatic hypoglycaemia occurred in 1.7% of lixisenatide treated patients and in 1.6% of placebo treated patients.
Danish: Hos patienter, der tog Lyxumia som monoterapi, forekom symptomatisk hypoglykæmi hos 1,7 % af lixisenatidbehandlede patienter og hos 1,6 % af placebobehandlede patienter.
English: Lyxumia should not be used with a combination of both basal insulin and sulphonylurea
Danish: Lyxumia må ikke bruges i kombination med både basalinsulin og sulfonylurinstof
English: In a clinical study, the addition of lixisenatide to pioglitazone with or without metformin, in patients not adequately controlled with pioglitazone, resulted in an HbA1c decrease from baseline of 0.90%, compared to a decrease from baseline of 0.34% in the placebo group at the end of the 24-week main treatment period.
Danish: I et klinisk studium medførte tillæg af lixisenatid til pioglitazon med eller uden metformin en HbA1creduktion fra baseline på 0,90 %, sammenlignet med 0,34 % i placebogruppen ved afslutning af den 24-ugers behandlingsperiode, hos patienter, som ikke var tilstrækkeligt kontrolleret med pioglitazon.
English: Lyxumia given with a basal insulin alone, or with a combination of a basal insulin and metformin, or a combination of a basal insulin and a sulphonylurea resulted in statistically significant reductions in HbA1c and in 2-hour post-prandial glucose after a test-meal compared to placebo.
Danish: Lyxumia givet sammen med basalinsulin alene, eller med en kombination af basalinsulin og metformin, eller en kombination af basalinsulin og et sulfonylurinstof, resulterede i statistisk signifikant reduktion i HbA1c og i 2-timers postprandial glucose efter et testmåltid sammenlignet med placebo.
English: Upper respiratory tract infection
Danish: Øvre luftvejsinfektion Cystitis
English: Other medicines and Lyxumia
Danish: Brug af anden medicin sammen med Lyxumia
English: Lyxumia 10 micrograms solution for injection EU/1/12/811/001 (1 pre-filled pen)
Danish: Lyxumia 10 mikrogram injektionsvæske, opløsning EU/1/12/811/001 (1 fyldt pen)
English: When to inject
Danish: Hvornår det skal injiceres
English: Packs containing 1, 2 and 6 purple pre-filled pens.
Danish: Pakninger indeholdende 1, 2 og 6 lilla, fyldte penne.
English: Based on these results, no dose adjustment for ramipril is required when co-administered with lixisenatide.
Danish: Baseret på disse resultater kræves der ingen dosisjustering for ramipril ved administration samtidig med lixisenatid.
English: At the end of the 24-week treatment period, 56.3% of the lixisenatide patients achieved an HbA1c less than 7 % compared to 38.5% in the placebo group.
Danish: Ved afslutningen af den 24-ugers behandlingsperiode havde 56,3 % af lixisenatidpatienterne opnået et HbA1c på under 7 % sammenlignet med 38,5 % i placebogruppen.
English: • Once activated, store your Lyxumia pen below 30°C.
Danish: • Når din Lyxumia-pen er aktiveret, skal den opbevares under 30 °C.
English: Lixisenatide should not be given in combination with basal insulin and a sulphonylurea due to increased risk of hypoglycaemia.
Danish: Lixisenatid bør ikke gives i kombination med basalinsulin og et sulfonylurinstof på grund af risikoen for hypoglykæmi.
English: Patients (%) achieving HbA1c
Danish: Patienter (%) som opnåede HbA1c < 7,0 %
English: Line up the needle with the pen.
Danish: Juster nålen ind efter pennen.
English: Squeeze the outer needle cap to grip the needle and use it to unscrew the needle from the pen.
Danish: Klem om det ydre nålehylster for at få fat om nålen og brug den til at skrue nålen ud af pennen.
English: When administered 1 or 4 hours after 10 mcg lixisenatide , Cmax of paracetamol was decreased by 29% and 31% respectively and median tmax was delayed by 2.0 and 1.75 hours respectively.
Danish: Ved administration 1 eller 4 timer efter 10 µg lixisenatid sænkedes Cmax for paracetamol med henholdsvis 29 % og 31 %, og median tmax blev forsinket med henholdsvis 2,0 og 1,75 timer.
English: Hydrochloric acid (for pH adjustment) Sodium hydroxide solution (for pH adjustment) Water for injections
Danish: Saltsyre (til pH-justering) Natriumhydroxidopløsning (til pH-justering) Vand til injektionsvæsker
English: Patients with hepatic impairment No dose adjustment is needed in patients with hepatic impairment (see section 5.2).
Danish: Patienter med nedsat leverfunktion Dosisjustering er ikke nødvendig til patienter med nedsat leverfunktion (se pkt.
English: Each cartridge is assembled into a disposable pen.
Danish: Hver cylinderampul er monteret i en engangspen.
English: Speak to your doctor, nurse or pharmacist about how to dispose of sharps.
Danish: Tal med lægen, sygeplejersken eller apotekspersonalet om hvordan du bortskaffer nåle.
English: Remove the protective seal from the outer needle cap.
Danish: Fjern den beskyttende forsegling fra det ydre nålehylster.
English: in case of vomiting, nausea and diarrhoea.
Danish: du oplever væsketab/dehydrering, f.eks. i tilfælde af opkastning, kvalme og diarré.
English: During the 24-week main treatment period, nausea was reported in 23.5% in the lixisenatide group compared to 10.6% in the placebo group and symptomatic hypoglycaemia was reported in 3.4% of the lixisenatide patients compared to 1.2% in the placebo group.
Danish: I løbet af den 24-ugers behandlingsperiode blev kvalme rapporteret hos 23,5 % af lixisenatidgruppen sammenlignet med 10,6 % i placebogruppen, og symptomatisk hypoglykæmi blev rapporteret hos 3,4 % af lixisenatidpatienterne sammenlignet med 1,2 % i placebogruppen.
English: Contact your doctor, pharmacist or nurse if you need help.
Danish: Kontakt din læge, apotekspersonalet eller sundhedspersonalet, hvis du har brug for hjælp.
English: When Lyxumia is used in combination with metformin alone, symptomatic hypoglycaemia occurred in 7.0% of lixisenatide patients and in 4.8% of placebo patients during the entire treatment period.
Danish: Når Lyxumia anvendtes i kombination med metformin alene, forekom symptomatisk hypoglykæmi hos 7,0 % af lixisenatidpatienterne og hos 4,8 % af placebopatienterne under hele behandlingsperioden.
English: Begin with the green 10 microgram Lyxumia pen.
Danish: Begynd med den grønne 10 mikrogram Lyxumia-pen.
English: During the 24-week treatment period, 22.4% lixisenatide patients reported at least one symptomatic hypoglycaemic event compared to 13.5% in the placebo group.
Danish: I løbet af den 24-ugers behandlingsperiode rapporterede 22,4 % af lixisenatidpatienterne mindst et symptomatisk hypoglykæmitilfælde sammenlignet med 13,5 % i placebogruppen.
English: Reduction from baseline in the AUC0:30-4:30 h of plasma glucose after a test-meal was: -12.61 h*mmol/L (-227.25 h*mg/dl) in the lixisenatide group and -4.04 h*mmol/L (-72.83 h*mg/dl) in the liraglutide group.
Danish: Reduktion fra baseline i AUC0:30-4:30 t for plasmaglucose efter et testmåltid var: -12,61 t∙mmol/l (-227,25 t∙mg/dl) i lixisenatidgruppen og -4,04 t∙mmol/l (72,83 t∙mg/dl) i liraglutid-gruppen.
English: Purple 20 microgram Lyxumia pen
Danish: Lilla 20 mikrogram Lyxumia-pen
English: Table 3: Placebo-controlled study in combination with a sulphonylurea (24-week results)
Danish: Tabel 3: Placebokontrollerede studier i kombination med et sulfonylurinstof (24-ugers resultater)
English: Lyxumia should not be given in combination with basal insulin and a sulphonylurea due to increased risk of hypoglycaemia (see section 4.4).
Danish: Lyxumia bør ikke gives i kombination med basalinsulin og et sulfonylurinstof på grund af forøget risiko for hypoglykæmi (se pkt.
English: • Replace the pen cap before you throw away your Lyxumia pen.
Danish: • Sæt pennens hætte på igen, før du kasserer Lyxumia-pennen.
English: Primary composite endpoint CV death, non-fatal MI, non-fatal stroke, or hospitalization for unstable angina
Danish: Primært sammensat endepunkt CV død, ikke-fatal MI 406 (13,4 %) 399 (13,2 %) Ikke-fatalt slagtilfælde, eller indlæggelse for ustabil angina
English: Gender Gender has no clinically relevant effect on the pharmacokinetics of lixisenatide.
Danish: Køn Køn har ingen klinisk relevant indvirkning på farmakokinetikken for lixisenatid.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (MAINTENANCE PACK)
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE ÆSKE (VEDLIGEHOLDELSESPAKNING)
English: These are the thigh, abdomen or upper arm.
Danish: Det vil sige i låret, maven eller overarmen.
English: • Do not store your Lyxumia pen with the needle attached.
Danish: • Opbevar ikke Lyxumia-pennen med nålen påsat.
English: You must start your treatment with the green pen of Lyxumia 10 micrograms.
Danish: Du skal starte din behandling med den grønne pen af Lyxumia 10 mikrogram.
English: At the end of the 24-week main treatment period, 52.3% of the lixisenatide patients achieved an HbA1c less than 7% compared to 26.4% in the placebo group.
Danish: Ved afslutning af den 24-ugers behandlingsperiode havde 52,3 % af lixisenatidpatienterne opnået HbA1c på under 7 % sammenlignet med 26,4 % i placebogruppen.
English: If no liquid comes out see the “Questions and answers” section.
Danish: Se afsnittet ”Spørgsmål og svar”, hvis der ikke kommer noget væske ud.
English: Check that the activation window is white.
Danish: Kontroller at aktiveringsvinduet er hvidt.
English: When Lyxumia is used in combination with a basal insulin with or without metformin, symptomatic hypoglycaemia occurred in 42.1% of lixisenatide patients and in 38.9% of placebo patients during the entire treatment period (3.2% absolute difference).
Danish: Når Lyxumia anvendtes i kombination med basalinsulin med eller uden metformin, forekom symptomatisk hypoglykæmi hos 42,1 % af lixisenatidpatienterne og hos 38,9 % af placebopatienterne under hele behandlingsperioden (3,2 % absolut forskel).
English: INFORMATION IN BRAILLE Lyxumia
Danish: INFORMATION I BRAILLE-SKRIFT
English: Age has no clinically relevant effect on the pharmacokinetics of lixisenatide.
Danish: Alder har ingen klinisk relevant indvirkning på farmakokinetikken for lixisenatid.
English: Lixisenatide 20 mcg Placebo (N= 170)
Danish: Lixisenatid 20 µg Placebo (N= 170)
English: However, when used in combination with a sulphonylurea or a basal insulin, blood glucose monitoring or blood glucose selfmonitoring may become necessary to adjust the doses of the sulphonylurea or the basal insulin.
Danish: Når det bruges i kombination med et sulfonylurinstof eller basalinsulin, kan det dog være nødvendigt med blodsukkermonitorering for at justere doserne af sulfonylurinstof eller basalinsulin.
English: If a dose is missed, it should be injected within the hour prior to the next meal.
Danish: Hvis patienten glemmer at tage en dosis Lyxumia, bør den injiceres inden for en time før det næste måltid.
English: LS change from baseline LS mean difference (SE) of lixisenatide versus 95% CI
Danish: MK-ændring fra baseline MK-middelændring fra baseline af lixisenatid versus 95 % konfidensinterval
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (INITIATION PACK)
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE YDRE ÆSKE (OPSTARTSPAKNING)
English: • Do not soak, wash or put liquid on (lubricate) your Lyxumia pen, this may damage it.
Danish: • Lyxumia-pennen må ikke lægges i vand, vaskes eller smøres med væske - det kan beskadige den.
English: It is not known if Lyxumia passes into your milk.
Danish: Det vides ikke, om Lyxumia udskilles i modermælken.
English: to 74 years and 7 subjects aged ≥75 years) compared to 18 subjects aged 18 to 45 years, likely related to reduced renal function in the older age group.
Danish: forsøgspersoner i alderen 18 til 45 år, sandsynligvis relateret til nedsat nyrefunktion i den ældre aldersgruppe.
English: Step B. Attach a new needle and remove the needle caps
Danish: Trin B Påsæt nålen og fjern nålehylster og nålekapsel
English: Animal studies did not indicate direct harmful effects with respect to male and female fertility in rats.
Danish: Dyrestudier indikerede ikke direkte skadelige virkninger på fertiliteten hos han- og hunrotter.
English: In patients taking Lyxumia in combination with a sulphonylurea and metformin, symptomatic hypoglycaemia occurred in 22.0% of lixisenatide treated patients and in 18.4% of placebo treated patients during the entire treatment period (3.6% absolute difference).
Danish: Hos patienter, der tog Lyxumia i kombination med et sulfonylurinstof og metformin, forekom symptomatisk hypoglykæmi hos 22,0 % af de Lyxumia-behandlede patienter og hos 18,4 % af de placebobehandlede patienter under hele behandlingsperioden (3,6 % absolut forskel).
English: Put the outer needle cap on a flat surface.
Danish: Anbring det ydre nålehylster på en plan flade.
English: In the subset of patients (5.2%) with the highest antibody concentrations, the mean improvement in HbA1c at Week 24 and at Week 76 was in a clinically relevant range; however there was variability in the glycaemic response and 1.9% had no decrease in HbA1c.
Danish: I den del af patienter, (5,2 %) der havde den højeste antistofkoncentration, var den gennemsnitlige forbedring i HbA1c i uge 24 og uge 76 i et klinisk relevant niveau.
English: Purple 20 microgram pen Use
Danish: Brug af lilla 20 mikrogram pen
English: You must dispose of the needle after each use, in an appropriate sharp's container, following local recommendations.
Danish: Kasser nålen efter brug i en punkterfast beholder, følg anbefalede retningslinjer.
English: Read these instructions carefully before using your Lyxumia pens.
Danish: Læs Brugsanvisningen grundigt før du bruger dine Lyxumia-penne.
English: • Talk with your doctor, pharmacist or nurse about how to inject correctly before using it.
Danish: • Tal med din læge, apotekspersonalet eller sundhedspersonalet om, hvordan du injicerer korrekt,
English: Then use the purple 20 micrograms Lyxumia pen.
Danish: Derefter bruges den lilla 20 mikrogram Lyxumia-pen.
English: Lixisenatide 20 mcg (N= 160)
Danish: Lixisenatid 20 µg (N= 160)
English: Vistor hf.
Danish: Primære + HF + revask.